Striving for optimal bronchodilation: focus on olodaterol.

导出 OA

翻译打印收藏纠错

作者： Cristoforo,Incorvaia ^[1] ; Marcello,Montagni ^[2] ; Elena,Makri ^[1] ; Gian Galeazzo,Riario-Sforza ^[1] ; Erminia,Ridolo ^[2]

作者单位： Allergy/Pulmonary Rehabilitation, Istituti Clinici di Perfezionamento Hospital, Milan, Italy. ^[1] Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy. ^[2]

关键词 COPD bronchodilators efficacy olodaterol safety very long acting β2-agonists

主题词苯并恶嗪类(Benzoxazines);支气管扩张药(Bronchodilator Agents);临床试验(主题)(Clinical Trials as Topic);人类(Humans);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive)

DOI 10.2147/COPD.S96070

PMID 27042036

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览48

International journal of chronic obstructive pulmonary disease

2016年11卷

439-44页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Striving for optimal bronchodilation: focus on olodaterol.

International journal of chronic obstructive pulmonary disease

相似文献

International journal of chronic obstructive pulmonary disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Striving for optimal bronchodilation: focus on olodaterol.

International journal of chronic obstructive pulmonary disease

相似文献

International journal of chronic obstructive pulmonary disease

相关期刊

检索历史清除